Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details 1)

v3.19.3
Stock Based Compensation (Details 1)
$ / shares in Units, $ in Thousands
6 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Stock grants outstanding, beginning | shares 350,000
Number of stock grants granted | shares 0
Number of stock grants exercised/vested | shares (50,000)
Number of stock grants forfeited/cancelled/expired | shares 0
Stock grants outstanding, ending | shares 300,000
Stock grants exercisable | shares 60,000
Weighted average exercise price outstanding, beginning $ 1.98
Weighted average exercise price granted 0
Weighted average exercise price exercised 1.98
Weighted average exercise price forfeited/cancelled/expired 0
Weighted average exercise price outstanding, ending 1.98
Weighted average exercise price exercisable $ 1.98
Weighted average remaining contractual life, options outstanding, beginning 8 years 6 months 7 days
Weighted average remaining contractual life, options outstanding, ending 8 years 7 days
Weighted average remaining contractual life, options exercisable 8 years 7 days
Aggregate intrinsic value outstanding, beginning | $ $ 2,342
Aggregate intrinsic value granted | $ 0
Aggregate intrinsic value exercised | $ $ 394
Aggregate intrinsic value forfeited/cancelled/expired $ 0
Aggregate intrinsic value outstanding, ending | $ $ 2,958
Aggregate intrinsic value exercisable | $ $ 592
Restricted Stock  
Stock grants outstanding, beginning | shares 2,275,000
Number of stock grants granted | shares 0
Number of stock grants exercised/vested | shares 0
Number of stock grants forfeited/cancelled/expired | shares 0
Stock grants outstanding, ending | shares 2,275,000
Weighted average exercise price outstanding, beginning $ 4,777
Weighted average exercise price granted 0
Weighted average exercise price exercised 0
Weighted average exercise price forfeited/cancelled/expired 0
Weighted average exercise price outstanding, ending $ 4,777